Success Metrics

Clinical Success Rate
85.7%

Based on 6 completed trials

Completion Rate
86%(6/7)
Active Trials
0(0%)
Results Posted
50%(3 trials)
Terminated
1(14%)

Phase Distribution

Ph phase_4
5
71%
Ph not_applicable
2
29%

Phase Distribution

0

Early Stage

0

Mid Stage

5

Late Stage

Phase Distribution7 total trials
Phase 4Post-market surveillance
5(71.4%)
N/ANon-phased studies
2(28.6%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

85.7%

6 of 7 finished

Non-Completion Rate

14.3%

1 ended early

Currently Active

0

trials recruiting

Total Trials

7

all time

Status Distribution
Completed(6)
Terminated(1)

Detailed Status

Completed6
Terminated1

Development Timeline

Analytics

Development Status

Total Trials
7
Active
0
Success Rate
85.7%
Most Advanced
Phase 4

Trials by Phase

Phase 45 (71.4%)
N/A2 (28.6%)

Trials by Status

completed686%
terminated114%

Recent Activity

Clinical Trials (7)

Drug Details

Intervention Type
DRUG
Total Trials
7